Price$16.59+6.68 (+67.36%)
2026-03-052026-06-08
News · 26 weeks410%
2025-12-142026-06-07
Mix2690d
- Insider13(50%)
- SEC Filings7(27%)
- Other4(15%)
- Earnings2(8%)
Latest news
25 items- INSIDERChief Operating Officer Morais Mark A. converted options into 11,006 shares and sold $75,374 worth of shares (4,866 units at $15.49), increasing direct ownership by 9% to 76,039 units (SEC Form 4) (tax withholding)4 - Fortrea Holdings Inc. (0001965040) (Issuer)
- INSIDERChief Financial Officer Mcconnell Jill G. converted options into 11,006 shares and sold $75,374 worth of shares (4,866 units at $15.49), increasing direct ownership by 8% to 78,416 units (SEC Form 4) (withholding obligation)4 - Fortrea Holdings Inc. (0001965040) (Issuer)
- PRFortrea to Attend Jefferies Global Healthcare ConferenceDURHAM, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE), a leading global contract research organization ("CRO"), today announced that that CEO Anshul Thakral, CFO Jill McConnell, and SVP of Investor Relations, Tracy Krumme will participate in the following conference: Jefferies Global Healthcare Conference (NYC)Date: Thursday, June 4, 2026Time: 8:45 AM EDTFormat: Fireside Chat To register for the live webcast, please click here. A replay will be available in the Events & Presentations section of Fortrea's Investor Relations website. Investors interested in one-on-one or group meetings should contact their Jefferies representatives. About Fortrea Fortrea (NASDAQ:FTRE) is
- INSIDERChief Accounting Officer Parks Robert sold $26,880 worth of shares (2,000 units at $13.44), decreasing direct ownership by 9% to 20,389 units (SEC Form 4)4 - Fortrea Holdings Inc. (0001965040) (Issuer)
- INSIDERDirector Neupert Peter M converted options into 148,536 shares, increasing direct ownership by 151% to 246,668 units (SEC Form 4)4 - Fortrea Holdings Inc. (0001965040) (Issuer)
- SECSEC Form 144 filed by Fortrea Holdings Inc.144 - Fortrea Holdings Inc. (0001965040) (Subject)
- SECSEC Form 10-Q filed by Fortrea Holdings Inc.10-Q - Fortrea Holdings Inc. (0001965040) (Filer)
- SECFortrea Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Fortrea Holdings Inc. (0001965040) (Filer)
- PRFortrea Reports First Quarter 2026 ResultsStrong first-quarter performance reinforces confidence in FY 2026 guidanceBook-to-bill of 1.15x is third consecutive quarter above 1.1x Highlights For the three months ended March 31, 2026: Revenues of $636.5 millionBook-to-bill ratio of 1.15x, resulting in 1.05x book-to-bill for the trailing 12 monthsGAAP net loss of $(23.6) million, or $(0.25) per diluted shareAdjusted EBITDA of $47.0 millionAdjusted net income of $15.2 million, or $0.16 per diluted shareFull-year guidance affirmed DURHAM, N.C., May 05, 2026 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE) (the "Company"), a leading global contract research organization ("CRO"), today reported financial results for the first quarter ended M
- SECSEC Form DEFA14A filed by Fortrea Holdings Inc.DEFA14A - Fortrea Holdings Inc. (0001965040) (Filer)
- SECSEC Form DEF 14A filed by Fortrea Holdings Inc.DEF 14A - Fortrea Holdings Inc. (0001965040) (Filer)
- PRFortrea Announces Date for First Quarter 2026 Financial Results and Conference CallDURHAM, N.C., April 21, 2026 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE) (the "Company"), a leading global contract research organization (CRO), today announced that it will release its first quarter 2026 financial results before the market opens on Tuesday, May 5, 2026. The Company will host a conference call at 8:00 a.m. ET on that day to discuss the results. To participate in the conference call, participants should pre-register via the call registration link. All registrants will receive dial-in details and a unique PIN providing access to the live call. To avoid potential delays, participants are encouraged to join at least 10 minutes prior to the start of the call. The live webcast c
- PRFortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated TrialsHighlights: Designed to transform clinical trial operations for sponsors, sites and study teamsPersona driven, AI-powered solutions automate workflows and streamline oversight to help improve trial speed, predictability and qualityBuilds on Fortrea's flagship platform Xcellerate® to deliver near-real-time, role-based insights DURHAM, N.C., April 07, 2026 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE), a leading global clinical research organization (CRO), today unveiled Fortrea Intelligent Technology™(FIT), a suite of innovative technology solutions designed to transform clinical trial operations. By integrating persona-driven, AI-powered solutions that automate workflows, streamline oversig
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Fortrea Holdings Inc.SCHEDULE 13G/A - Fortrea Holdings Inc. (0001965040) (Subject)
- INSIDERSEC Form 4 filed by Russell Erin L4 - Fortrea Holdings Inc. (0001965040) (Issuer)
- INSIDERChief Operating Officer Morais Mark A. sold $16,633 worth of shares (1,804 units at $9.22) and converted options into 4,284 shares, increasing direct ownership by 4% to 69,899 units (SEC Form 4)4 - Fortrea Holdings Inc. (0001965040) (Issuer)
- INSIDERChief Financial Officer Mcconnell Jill G. converted options into 4,284 shares and sold $16,633 worth of shares (1,804 units at $9.22), increasing direct ownership by 4% to 72,276 units (SEC Form 4)4 - Fortrea Holdings Inc. (0001965040) (Issuer)
- INSIDERSEC Form 4 filed by Fortrea Holdings Inc.4 - Fortrea Holdings Inc. (0001965040) (Issuer)
- INSIDERSEC Form 4 filed by Fortrea Holdings Inc.4 - Fortrea Holdings Inc. (0001965040) (Issuer)
- INSIDERSEC Form 4 filed by Fortrea Holdings Inc.4 - Fortrea Holdings Inc. (0001965040) (Issuer)
- INSIDERSEC Form 4 filed by Chief Accounting Officer Parks Robert4 - Fortrea Holdings Inc. (0001965040) (Issuer)
- INSIDERSEC Form 4 filed by Chief Operating Officer Morais Mark A.4 - Fortrea Holdings Inc. (0001965040) (Issuer)
- INSIDERSEC Form 4 filed by Chief Financial Officer Mcconnell Jill G.4 - Fortrea Holdings Inc. (0001965040) (Issuer)
- PRFortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)DURHAM, N.C., March 10, 2026 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE) (the "Company"), a leading global contract research organization, today announced the granting of an inducement award of restricted stock units ("RSUs") on March 10, 2026, to four newly hired employees. The award consisted of 130,000 RSUs that vest in three equal annual installments starting March 10, 2027, subject to the employee's continuous employment through the applicable vesting date. The RSUs are subject to the terms and conditions of the Company's Amended and Restated 2025 Inducement Award Plan and the award agreements covering the grants. These awards follow Nasdaq Listing Rule 5635(c)(4) and are intended as an
- SECSEC Form 144 filed by Fortrea Holdings Inc.144 - Fortrea Holdings Inc. (0001965040) (Subject)
FTRE FAQ
5 questionsWhere does FTRE stock trade?
Fortrea Holdings Inc. (FTRE) is listed on NASDAQ.What sector and industry is FTRE in?
Fortrea Holdings Inc. operates in the Health Care sector, Medical Specialities industry.What are analysts saying about FTRE?
Fortrea Holdings Inc. has had 8 recent analyst actions on file. The most recent action was from TD Cowen: Buy with a $1500.00 price target on 2026-03-09. Recent price targets range from $600.00 to $2500.00.What companies are similar to FTRE?
Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), ANTM (Anthem Inc.), ELV (Elevance Health Inc.), CI (The Cigna Group), HUM (Humana Inc.). Compare FTRE side-by-side with any of them on Quantisnow.How can I track FTRE on Quantisnow?
Quantisnow aggregates Fortrea Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow FTRE to receive live email and push alerts on every new disclosure.